Published in Am J Cardiol on November 01, 1996
Percutaneous balloon-expandable stents for sealing of acute aortic dissection. Tex Heart Inst J (2000) 0.75
Genome sequence of Halobacterium species NRC-1. Proc Natl Acad Sci U S A (2000) 5.87
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature (1982) 3.82
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Frizzled-7 signalling controls tissue separation during Xenopus gastrulation. Nature (2001) 2.92
Pregnancy outcomes of Indochinese refugees, Santa Clara County, California. Am J Public Health (1982) 2.60
Genetic evidence and new morphometric data as essential tools to identify the Patagonian seahorse Hippocampus patagonicus (Pisces, Syngnathidae). J Fish Biol (2014) 1.97
Control of hypertension in coronary heart disease. Int J Cardiol (2008) 1.93
Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology (2009) 1.91
AccII polymorphism of the p53 gene. Nucleic Acids Res (1990) 1.80
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol (1998) 1.69
Immediate and follow-up results of transluminal balloon dilation for discrete subaortic stenosis. J Am Coll Cardiol (1991) 1.68
Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol (1990) 1.61
Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful? Am J Gastroenterol (1990) 1.60
The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J Biol Chem (2001) 1.59
Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications. Endocrinology (2010) 1.59
Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. Circ Res (1998) 1.56
Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Intervent Radiol (2001) 1.55
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol (2000) 1.55
Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol (2000) 1.54
Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC) Circulation (1990) 1.54
Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol (2000) 1.52
Unplanned redundant publication. A consequence of too many cardiovascular journals? Heart (2010) 1.50
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther (1999) 1.49
CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res (1994) 1.49
Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Haematologica (1999) 1.48
Adherence of viable and nonviable bacteria to soft contact lenses. Cornea (1989) 1.46
Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? Circulation (2000) 1.46
Heart rate variability and inappropriate sinus tachycardia after catheter ablation of supraventricular tachycardia. Eur Heart J (1995) 1.42
Balloon valvuloplasty for mild mitral stenosis. Cathet Cardiovasc Diagn (1991) 1.42
Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing. Anal Bioanal Chem (2010) 1.42
Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome. Environ Health Perspect (2001) 1.41
[Anomalous origin of the right coronary artery]. Rev Esp Cardiol (2000) 1.39
Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol (1990) 1.38
Effect of melatonin on myocardial oxidative stress induced by experimental obstructive jaundice. Rev Esp Enferm Dig (2009) 1.38
Multicenter retrospective study of response to interferon in chronic hepatitis B. Rev Esp Enferm Dig (2000) 1.38
[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia]. Med Clin (Barc) (2001) 1.38
Gestational sac volume: comparison between SonoAVC and VOCAL measurements at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol (2009) 1.38
Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg (1996) 1.37
Depressive disorders in primary care: prevalence, functional disability, and identification. J Gen Intern Med (1995) 1.34
The architecture of the atrial musculature between the orifice of the inferior caval vein and the tricuspid valve: the anatomy of the isthmus. J Cardiovasc Electrophysiol (1998) 1.34
Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res (1991) 1.33
Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg (1998) 1.33
Percutaneous interventions on severe coarctation of the aorta: a 21-year experience. Pediatr Cardiol (2005) 1.33
Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med (2001) 1.31
Effects of mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care Med (1994) 1.31
Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology (1997) 1.30
Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation. Leukemia (2005) 1.29
Balloon-expandable stent repair of severe coarctation of aorta. Am Heart J (1995) 1.29
Immediate and follow-up findings after stent treatment for severe coarctation of aorta. Am J Cardiol (1999) 1.28
The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system. Endocrinology (2009) 1.28
Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre. Eur J Clin Pharmacol (1988) 1.28
The etiology of maternal mortality in developing countries: what do verbal autopsies tell us? Bull World Health Organ (2001) 1.27
Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes (2000) 1.27
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet Rec (1997) 1.25
Auricular acupuncture for pain relief after total hip arthroplasty - a randomized controlled study. Pain (2005) 1.22
The mode of spread of Hodgkin's disease to the skin. Cancer (1970) 1.22
Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. J Urban Health (2001) 1.21
A role for calnexin in the assembly of the MHC class I loading complex in the endoplasmic reticulum. J Immunol (2001) 1.20
Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ Health Perspect (2000) 1.20
3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem Res Toxicol (2001) 1.16
Angiographic anatomy of the inferior right atrial isthmus in patients with and without history of common atrial flutter. Circulation (1999) 1.14
Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Clin Chem (2000) 1.12
Pharmacology of MDMA in humans. Ann N Y Acad Sci (2000) 1.12
Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol (1990) 1.11
Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther (1993) 1.11
Electrospray mass spectrometry of testosterone esters: potential for use in doping control. Steroids (1997) 1.07
Needle-knife fistulotomy versus needle-knife precut papillotomy for the treatment of common bile duct stones. Gastrointest Endosc (1999) 1.06
KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction. Am J Physiol Endocrinol Metab (2009) 1.06
Unrecognised ventricular dysfunction in COPD. Eur Respir J (2011) 1.06
[Follow-up study after percutaneous mitral valvuloplasty. The COR-PAL experience]. Rev Esp Cardiol (1992) 1.05
Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics. Leukemia (2005) 1.05
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther (2000) 1.05
Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus. Clin Exp Immunol (2009) 1.04